Femoral nerve blockade in hip fracture patients

Femoral nerve blockade in hip fracture patients: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN46653818

Enrollment

250

Registered

2009-05-05

Start date

2009-03-30

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture Injury, Occupational Diseases, Poisoning Fracture of femur

Interventions

Patients are randomised to femoral nerve blockade or the regular use of opioids. Both groups will receive 1 g of paracetamol 4 times/day. The patients in the intervention group will receive a femoral

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Both males and females, aged 70 years and above 2. All hip fracture patients admitted to the Orthopaedic Department

Exclusion criteria

Exclusion criteria: 1. Local infection 2. Allergic to local anaesthesia 3. Dying patients 4. Pathologic hip fractures

Design outcomes

Primary

Measure	Time frame
1. Post-operative delirium, assessed three times a day at the Orthopaedic Department 2. Post-operative complications, such as decubital ulcers, infections, thrombosis, heart failure, assessed three times a day at the Orthopaedic Department 3. Pain, assessed three times a day at the Orthopaedic Department A cognitive test will be assessed in the ambulance pre-hospitally and at 24 +/- 6 hours post-operatively. At days three to five a more thorough assessment will be done including delirium, depression, cognitive status, quality of life and more.	—

Measure

Time frame

1. Post-operative delirium, assessed three times a day at the Orthopaedic Department 2. Post-operative complications, such as decubital ulcers, infections, thrombosis, heart failure, assessed three times a day at the Orthopaedic Department 3. Pain, assessed three times a day at the Orthopaedic Department A cognitive test will be assessed in the ambulance pre-hospitally and at 24 +/- 6 hours post-operatively. At days three to five a more thorough assessment will be done including delirium, depression, cognitive status, quality of life and more.

—

Secondary

Measure	Time frame
1. Mortality 2. Orthopaedic recovery, recorded at the time of discharge from the hospital 3. EQ-5D 4. Economics A cognitive test will be assessed in the ambulance pre-hospitally and at 24 +/- 6 hours post-operatively. At days three to five a more thorough assessment will be done including delirium, depression, cognitive status, quality of life and more.	—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026